Dr
Nienke
Lubben

Partner & Patent Attorney

York Office The Hague Office

Life sciences

Telephone. +44(0) 1904 732 120
Mobile. +44(0) 777 265 2294
Email. [email protected]

Experience

Nienke's portfolio encompasses a diverse range of biological subject matter including: cell therapy, biomarkers, biosimilars, antibodies, immunology, therapeutics, cell biology, biotechnology, enzymology, diagnostics and biopharmaceuticals. She handles all patent related matters including: preparing patent applications, prosecuting patent applications before the EPO and UKIPO, managing worldwide patent prosecution, strategic reviews, due diligence, and validity opinions.

Nienke has considerable experience working with universities and spin-out companies and can bring a depth of commercially relevant advice from her experience in working for a start-up biotech company prior to entering the profession. Nienke also works with SMEs and large multinational companies. Her pragmatic advice is appropriately tailored to her client's individual needs.

Nienke has represented clients before the Oppositions Division of the EPO and has a particular interest in opposition matters. Her ability to quickly assimilate and utilise scientific literature to the benefit of her clients is a key strength during oral proceedings before both the Opposition Division and the Boards of Appeal of the EPO.

Nienke qualified as a Patent Attorney in 2012 and was awarded the Strode Prize for obtaining the highest mark in the UK finals law exam, P2. She also holds a Post-Graduate Certificate in Intellectual Property Law from the Queen Mary, University of London, obtained with distinction. She obtained her PhD from the University of Cambridge in Infection and Immunity and graduated with a First Class Honours degree in Biological Sciences (Genetics) from the University of Leicester with the highest mark in her year.

Qualifications

Patent Attorney

Chartered (UK)
Europe


BSC

Biological Sciences (genetics)

PHD

Infection and Immunity

Recognition

MIP IP Rising Star 2019/20

MIP IP Rising Star 2018/19

Publications

MIP IP Rising Stars 2019/20

View publication online

Related News

From Theoretical Proposals to Commercial Reality: The Rise of Innovation and Patent Filings in Quantum Computing

The possibility of quantum computing was first seriously proposed in the early 1980s and is widely regarded as having enormous potential to deliver a step change in the complexity of …

Read article
Event - 3rd February 2023

The European Patent Office are running an inspiring collaborative art competition for children

To celebrate the 50th anniversary of the signing of the European Patent Convention, The European Patent Office (EPO) is running a collaborative art competition for primary schools on the topic …

Event details
Event - 8th-9th February 2023

5th Annual Microbiome & Probiotic Conference 2023

The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …

Event details
Event - 17th January 2023

CIPA Webinar: Enhancing Diversity in the Patent Profession How Can I Help

CIPA hosted a webinar to discuss ‘Enhancing diversity in the patent profession.’ Date Tuesday 17 January, 2023 Time 12.30pm – 1.30pm (GMT) Equity, diversity and inclusion has been in the …

Event details

LiDAR: A Significant Support Technology at CES

When visiting CES’ one thing that struck me was the number of companies demonstrating LiDAR technology. LiDAR has been around since the 1960s and was originally developed for aerospace use, …

Read article

Healthcare and Climate Change

Can we find a balance between intellectual property rights and public health needs when tackling the climate crisis? “The world faces a critical juncture. A health-centred, aligned response to the …

Read article

Navigating the CRISPR IP confusion

It is just over 10 years since the Science publication of Jinek et al. showed for the first time that DNA cleavage could be achieved in vitro with a Cas9 …

Read article

CRISPR Edited T cells win the TvT Battle

T-cells which have been modified using CRISPR base editing technology have been successfully used to treat T-cell acute lymphoblastic leukaemia for the first time {1}. A 13 year old patient …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.